Terms: = Prostate cancer AND EWSR1, EWS, 2130, ENSG00000182944 AND Treatment
14 results:
1. Targeted prostate Biopsy and MR-Guided Therapy for prostate cancer.
Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
Adv Exp Med Biol; 2018; 1096():159-184. PubMed ID: 30324353
[TBL] [Abstract] [Full Text] [Related]
2. Supporting prostate cancer survivors in primary care: Findings from a pilot trial of a nurse-led psycho-educational intervention (PROSPECTIV).
Watson EK; Shinkins B; Matheson L; Burns RM; Frith E; Neal D; Hamdy F; Walter FM; Weller D; Wilkinson C; Faithfull S; Sooriakumaran P; Kastner C; Campbell C; Neal RD; Butcher H; Matthews M; Perera R; Wolstenholme J; Rose PW
Eur J Oncol Nurs; 2018 Feb; 32():73-81. PubMed ID: 29353635
[TBL] [Abstract] [Full Text] [Related]
3. Results of multiparametric transrectal ultrasound-based focal high-dose-rate dose escalation combined with supplementary external beam irradiation in intermediate- and high-risk localized prostate cancer patients.
Kovács G; Müller K; Soror T; Melchert C; Guo X; Jocham D; Merseburger A
Brachytherapy; 2017; 16(2):277-281. PubMed ID: 27964906
[TBL] [Abstract] [Full Text] [Related]
4. CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling.
Manara MC; Terracciano M; Mancarella C; Sciandra M; Guerzoni C; Pasello M; Grilli A; Zini N; Picci P; Colombo MP; Morrione A; Scotlandi K
Oncotarget; 2016 Nov; 7(48):79925-79942. PubMed ID: 27835596
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy of synbiotics to reduce acute radiation proctitis symptoms and improve quality of life: a randomized, double-blind, placebo-controlled pilot trial.
Nascimento M; Aguilar-Nascimento JE; Caporossi C; Castro-Barcellos HM; Motta RT
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):289-95. PubMed ID: 25304789
[TBL] [Abstract] [Full Text] [Related]
6. [Methylation and protein expression of RASSF2 in prostate cancer].
Liu G; Yin B; Song YS
Zhonghua Nan Ke Xue; 2013 Feb; 19(2):107-10. PubMed ID: 23441448
[TBL] [Abstract] [Full Text] [Related]
7. ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells.
Magistroni V; Mologni L; Sanselicio S; Reid JF; Redaelli S; Piazza R; Viltadi M; Bovo G; Strada G; Grasso M; Gariboldi M; Gambacorti-Passerini C
PLoS One; 2011; 6(11):e28162. PubMed ID: 22140532
[TBL] [Abstract] [Full Text] [Related]
8. Analysis of prognostic factors of pediatric-type sarcomas in adult patients.
Ahn HK; Uhm JE; Lee J; Lim DH; Seo SW; Sung KS; Lee SJ; Lee DJ; Baek KK; Kim WS; Park JO
Oncology; 2011; 80(1-2):21-8. PubMed ID: 21606660
[TBL] [Abstract] [Full Text] [Related]
9. YK-4-279 inhibits ERG and ETV1 mediated prostate cancer cell invasion.
Rahim S; Beauchamp EM; Kong Y; Brown ML; Toretsky JA; Üren A
PLoS One; 2011 Apr; 6(4):e19343. PubMed ID: 21559405
[TBL] [Abstract] [Full Text] [Related]
10. Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies.
Kollmannsberger C; Tyldesley S; Moore C; Chi KN; Murray N; Daneshmand S; Black P; Duncan G; Hayes-Lattin B; Nichols C
Ann Oncol; 2011 Apr; 22(4):808-814. PubMed ID: 20926549
[TBL] [Abstract] [Full Text] [Related]
11. Identification of new prostate stem cell antigen-derived peptides immunogenic in HLA-A2(+) patients with hormone-refractory prostate cancer.
Matsueda S; Kobayashi K; Nonaka Y; Noguchi M; Itoh K; Harada M
Cancer Immunol Immunother; 2004 Jun; 53(6):479-89. PubMed ID: 14634796
[TBL] [Abstract] [Full Text] [Related]
12. Adenovirus 5 early region 1A does not induce expression of the ewing sarcoma fusion product ews-FLI1 in breast and ovarian cancer cell lines.
Meric F; Liao Y; Lee WP; Pollock RE; Hung MC
Clin Cancer Res; 2000 Oct; 6(10):3832-6. PubMed ID: 11051226
[TBL] [Abstract] [Full Text] [Related]
13. A link between basic fibroblast growth factor (bFGF) and ews/FLI-1 in Ewing's sarcoma cells.
Girnita L; Girnita A; Wang M; Meis-Kindblom JM; Kindblom LG; Larsson O
Oncogene; 2000 Aug; 19(37):4298-301. PubMed ID: 10980604
[TBL] [Abstract] [Full Text] [Related]
14. [Results of interstitial radiotherapy using I-125 seeds in the treatment of prostatic cancer].
Rohloff R; Tauber R; Schätzl M; Wendt T; Willich N
Strahlenther Onkol; 1988 Apr; 164(4):195-201. PubMed ID: 3363484
[TBL] [Abstract] [Full Text] [Related]
